Company Analysis China National Accord Medicines Corporation Ltd.
1. Summary
Advantages
- Price (12.5 Β₯) is less than fair price (14.04 Β₯)
- Dividends (6.04%) are higher than the sector average (1.83%).
- The stock's return over the last year (-11.72%) is higher than the sector average (-36.11%).
- Current debt level 0% is below 100% and has decreased over 5 years from 6.13%.
Disadvantages
- The company's current efficiency (ROE=10.15%) is lower than the sector average (ROE=11.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| China National Accord Medicines Corporation Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.5% | -4.6% | -1.1% |
| 90 days | -15.7% | -16% | 19.1% |
| 1 year | -11.7% | -36.1% | 43.2% |
200028 vs Sector: China National Accord Medicines Corporation Ltd. has outperformed the "Healthcare" sector by 24.39% over the past year.
200028 vs Market: China National Accord Medicines Corporation Ltd. has significantly underperformed the market by -54.92% over the past year.
Stable price: 200028 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 200028 with weekly volatility of -0.2254% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (12.5 Β₯) is lower than the fair price (14.04 Β₯).
Price not significantly lower than the fair price: The current price (12.5 Β₯) is slightly lower than the fair price by 12.3%.
4.2. P/E
P/E vs Sector: The company's P/E (4.78) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (4.78) is lower than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.46) is lower than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (0.46) is lower than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.1) is lower than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (0.1) is lower than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.28) is lower than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (8.28) is lower than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 2.83% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (2.83%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (10.15%) is lower than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (10.15%) is higher than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (3.23%) is lower than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (3.23%) is lower than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 6.04% is higher than the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 6.04% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 6.04% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (16.61%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
